{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:57:10Z","timestamp":1784631430219,"version":"3.55.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["No. ZR2016HM68"],"award-info":[{"award-number":["No. ZR2016HM68"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Arginineemia, also known as arginase deficiency, is a rare autosomal recessive metabolic disease. The diagnosis sometimes may be delayed due to atypical clinical manifestations. Confirmation of arginineemia depends on genetic testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We reported a Chinese male child presenting with hyperargininemia and progressive spastic diplegia, who has a novel compound heterozygous mutation in the arginase-1 (<jats:italic toggle=\"yes\">ARG1<\/jats:italic>) gene (c.263-266delAGAA, p.K88Rfs<jats:sup>\u2217<\/jats:sup>45;c.674T&gt;C,p.L216P), respectively, coming from his mother and father.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The patient was diagnosed with argininemia with a novel compound homozygous mutation of the <jats:italic toggle=\"yes\">ARG1<\/jats:italic> gene at the age of 12 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient had a low-protein diet (0.8\u200ag\/kg\/day). Baclofen, eperisone hydrochloride, botulinum toxin, and rehabilitation training were used to improve his spastic diplegia symptoms for 3 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient's blood arginine was still high after 3 months\u2019 low-protein diet. His spastic diplegia symptoms had not aggravated after 3 months\u2019 treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Argininemia should be considered in a patient with slowly progressive neurologic manifestations, especially spastic diplegia. This case also suggests that tandem mass spectrometry should be used as an effective tool in the validity of neonatal screening for early diagnosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021634","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T20:02:35Z","timestamp":1596571355000},"page":"e21634","source":"Crossref","is-referenced-by-count":7,"title":["A novel compound heterozygous mutation in the arginase-1 gene identified in a Chinese patient with argininemia"],"prefix":"10.1097","volume":"99","author":[{"given":"Dongqing","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","article-title":"The incidence of urea cycle disorders","volume":"110","author":"Summar","year":"2013","journal-title":"Mol Genet Metab"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ymgme.2014.06.005","article-title":"Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders","volume":"113","author":"Burrage","year":"2014","journal-title":"Mol Genet Metab"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/adc.50.1.57","article-title":"Familial hyperargininaemia","volume":"50","author":"Terheggen","year":"1975","journal-title":"Arch Dis Child"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1172\/JCI114707","article-title":"Molecular basis of argininemia. Identification of two discrete frame-shift deletions in the liver-type arginase gene","volume":"86","author":"Haraguchi","year":"1990","journal-title":"J Clin Invest"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pediatrneurol.2010.11.003","article-title":"Argininemia presenting with progressive spastic diplegia","volume":"44","author":"Lee","year":"2011","journal-title":"Pediatr Neurol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajmg.c.30091","article-title":"Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency","volume":"142C","author":"Scaglia","year":"2006","journal-title":"Am J Med Genet"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pediatrneurol.2012.03.016","article-title":"Clinical features and neurologic progression of hyperargininemia","volume":"46","author":"Carvalho","year":"2012","journal-title":"Pediatr Neurol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/088307389701200502","article-title":"Argininemia: a treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: case reports and literature review","volume":"12","author":"Prasad","year":"1997","journal-title":"J Child Neurol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/8904_2011_101","article-title":"Hyperargininemia: a family with a novel mutation in an unexpected site","volume":"5","author":"Cohen","year":"2012","journal-title":"JIMD Rep"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"e9880","DOI":"10.1097\/MD.0000000000009880","article-title":"Argininemia as a cause of severe chronic stunting and partial growth hormone deficiency (PGHD): a case report","volume":"97","author":"Cai","year":"2018","journal-title":"Medicine"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00726-015-2032-z","article-title":"Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature","volume":"47","author":"Schlune","year":"2015","journal-title":"Amino Acids"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01846026","article-title":"Diagnostic value of orotic acid excretion in heritable disorders of the urea cycle and in hyperammonemia due to organic acidurias","volume":"134","author":"Bachmann","year":"1980","journal-title":"Eur J Pediatr"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000493678","article-title":"Coagulation disturbances in patients with argininemia","volume":"140","author":"Kiykim","year":"2018","journal-title":"Acta Haematol"},{"issue":"(suppl 1)","key":"R14-20230915","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.ymgme.2010.02.020","article-title":"Creatine metabolism and the urea cycle","volume":"100","author":"Brosnan","year":"2010","journal-title":"Mol Genet Metab"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.parkreldis.2006.06.002","article-title":"Botulinum toxin: clinical use","volume":"12","author":"DD","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/BPB.0000000000000234","article-title":"Arginiemia is not a contraindication for botulinum toxin injection","volume":"25","author":"Kelle","year":"2016","journal-title":"J Pediatr Orthop B"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2011.06.025","article-title":"Arginase I deficiency: severe infantile presentation with hyperammonemia: more common than reported?","volume":"104","author":"Jain-Ghai","year":"2011","journal-title":"Mol Genet Metab"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:43:54Z","timestamp":1694825034000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021634"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":17,"journal-issue":{"issue":"32","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021634","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,7]]}}}